Podcasts
Blog
Podcasts
Blog
Trastuzumab Deruxtecan Benefits Patients with HER2-Low Metastatic Breast Cancer Irrespective of ER Expression
08.22.2023 -
By
Download our free app to listen on your phone
More episodes from Oncology Times - OncTimes Talk